Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy
Tzu‐Chieh Ho, Hye Sung Kim, Yumei Chen, et al.
Science Advances (2021) Vol. 7, Iss. 21
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Nanomedicine in cancer therapy
Dahua Fan, Yongkai Cao, Meiqun Cao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 294
mRNA-based cancer therapeutics
Chuang LIU, Qiangqiang Shi, Xiangang Huang, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 8, pp. 526-543
Closed Access | Times Cited: 226
Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges
Eman A. Taha, Joseph Lee, Akitsu Hotta
Journal of Controlled Release (2022) Vol. 342, pp. 345-361
Open Access | Times Cited: 158
Carrier strategies boost the application of CRISPR/Cas system in gene therapy
Zunkai Xu, Qingnan Wang, Haiping Zhong, et al.
Exploration (2022) Vol. 2, Iss. 2
Open Access | Times Cited: 79
Non-viral delivery of the CRISPR/Cas system: DNAversusRNAversusRNP
Yi Lin, Ernst Wagner, Ulrich Lächelt
Biomaterials Science (2022) Vol. 10, Iss. 5, pp. 1166-1192
Open Access | Times Cited: 74
Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment
Xiujuan Han, Chunai Gong, Qingru Yang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 571-608
Open Access | Times Cited: 37
Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing
Min Qiu, Yamin Li, Hanan Bloomer, et al.
Accounts of Chemical Research (2021) Vol. 54, Iss. 21, pp. 4001-4011
Closed Access | Times Cited: 103
Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs
Yamin Li, Zhongfeng Ye, Hanyi Yang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 6, pp. 2624-2639
Open Access | Times Cited: 59
Cell Membrane-Cloaked Nanotherapeutics for Targeted Drug Delivery
Na-Hyun Lee, Sumin You, Ali Taghizadeh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2223-2223
Open Access | Times Cited: 45
Stem cell membrane-camouflaged targeted delivery system in tumor
Weiyue Zhang, Xin Huang
Materials Today Bio (2022) Vol. 16, pp. 100377-100377
Open Access | Times Cited: 45
Targeting nucleic acid-based therapeutics to tumors: Challenges and strategies for polyplexes
Victoria C. Vetter, Ernst Wagner
Journal of Controlled Release (2022) Vol. 346, pp. 110-135
Closed Access | Times Cited: 39
Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing
Zoya Iqbal, Khurrum Rehman, Jiang Xia, et al.
Biomaterials Science (2023) Vol. 11, Iss. 11, pp. 3762-3783
Closed Access | Times Cited: 36
Biomaterial‐based gene therapy
Yi Yu, Yijun Gao, Liming He, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 36
Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy
Lianlian Fan, Anhui Wei, Zihui Gao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114451-114451
Open Access | Times Cited: 28
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
Jinxin Li, Qiwei Wang, Yingli Han, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 26
High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications
Hanjin Seo, Leekang Jeon, Jaeyeong Kwon, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 13
Closed Access | Times Cited: 25
Nanobiomaterial vectors for improving gene editing and gene therapy
Shao Wei Hu, Tao Ding, Honghai Tang, et al.
Materials Today (2023) Vol. 66, pp. 114-136
Closed Access | Times Cited: 24
Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment
Shiyao Zhou, Yingjie Li, Qinjie Wu, et al.
MedComm – Biomaterials and Applications (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 10
Targeted delivery strategies: The interactions and applications of nanoparticles in liver diseases
Xiandi Meng, Ge Zhu, Yong‐Guang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116702-116702
Open Access | Times Cited: 9
Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing
Elizabeth Maria Clarissa, Mamata Karmacharya, Hyun‐Min Choi, et al.
Small (2025)
Closed Access | Times Cited: 1
Multifunctional Biomedical Materials Derived from Biological Membranes
Yuemin Wang, Xinyuan Xu, Xingyu Chen, et al.
Advanced Materials (2021) Vol. 34, Iss. 46
Closed Access | Times Cited: 46
Engineered mesenchymal stem cell-derived exosomes with high CXCR4 levels for targeted siRNA gene therapy against cancer
Shuyue Xu, Bin Liu, Junyi Fan, et al.
Nanoscale (2022) Vol. 14, Iss. 11, pp. 4098-4113
Closed Access | Times Cited: 38
Delivery strategies in treatments of leukemia
Tianyuan Ci, Wentao Zhang, Yingyu Qiao, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 6, pp. 2121-2144
Closed Access | Times Cited: 29
Enhancing CRISPR/Cas systems with nanotechnology
Rupali Chowdhry, Steven Z. Lu, Seungheon Lee, et al.
Trends in biotechnology (2023) Vol. 41, Iss. 12, pp. 1549-1564
Closed Access | Times Cited: 21
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Ankit Kumar Dubey, Ebrahim Mostafavi
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top